Sandbox: Shamila

Revision as of 20:47, 26 March 2018 by Shamila Habibi (talk | contribs)
Jump to navigation Jump to search

Mixed connective tissue disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mixed connective tissue disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox: Shamila On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox: Shamila

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox: Shamila

on Sandbox: Shamila

Sandbox: Shamila in the news

Blogs onSandbox: Shamila

Directions to Hospitals Treating Mixed connective tissue disease

Risk calculators and risk factors for Sandbox: Shamila

WikiDoc Resources for Sandbox: Shamila

Articles

Most recent articles on Sandbox: Shamila

Most cited articles on Sandbox: Shamila

Review articles on Sandbox: Shamila

Articles on Sandbox: Shamila in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sandbox: Shamila

Images of Sandbox: Shamila

Photos of Sandbox: Shamila

Podcasts & MP3s on Sandbox: Shamila

Videos on Sandbox: Shamila

Evidence Based Medicine

Cochrane Collaboration on Sandbox: Shamila

Bandolier on Sandbox: Shamila

TRIP on Sandbox: Shamila

Clinical Trials

Ongoing Trials on Sandbox: Shamila at Clinical Trials.gov

Trial results on Sandbox: Shamila

Clinical Trials on Sandbox: Shamila at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sandbox: Shamila

NICE Guidance on Sandbox: Shamila

NHS PRODIGY Guidance

FDA on Sandbox: Shamila

CDC on Sandbox: Shamila

Books

Books on Sandbox: Shamila

News

Sandbox: Shamila in the news

Be alerted to news on Sandbox: Shamila

News trends on Sandbox: Shamila

Commentary

Blogs on Sandbox: Shamila

Definitions

Definitions of Sandbox: Shamila

Patient Resources / Community

Patient resources on Sandbox: Shamila

Discussion groups on Sandbox: Shamila

Patient Handouts on Sandbox: Shamila

Directions to Hospitals Treating Sandbox: Shamila

Risk calculators and risk factors for Sandbox: Shamila

Healthcare Provider Resources

Symptoms of Sandbox: Shamila

Causes & Risk Factors for Sandbox: Shamila

Diagnostic studies for Sandbox: Shamila

Treatment of Sandbox: Shamila

Continuing Medical Education (CME)

CME Programs on Sandbox: Shamila

International

Sandbox: Shamila en Espanol

Sandbox: Shamila en Francais

Business

Sandbox: Shamila in the Marketplace

Patents on Sandbox: Shamila

Experimental / Informatics

List of terms related to Sandbox: Shamila

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Jesus Rosario Hernandez, M.D. [3], Mahshid Mir, M.D. [4]

Synonyms and keywords: MCTD; mixed connective tissue disorder; Sharp's syndrome

Overview

Mixed connective tissue disease (MCTD) or Sharp's syndrome is a human autoimmune disease in which the immune system attacks the body. MCTD combines features of polymyositis, systemic lupus erythematosus, and systemic scleroderma and is thus considered an overlap syndrome. MCTD commonly causes joint pain/swelling, Raynaud phenomenon, muscle inflammation, and scarring of the skin of the hand. It does not typically cause kidney disease or seizures. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.[1]

Pathophysiology

There are no specific histologic findings that aid in the diagnosis of Mixed Connective Tissue Disorder as a separate autoimmune disease. For example, nephritis in MCTD is usually indistinguishable from lupus nephritis.

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mixed Connective Tissue Disease from other Diseases

Epidemiology and Demographics

Age

Gender

Race

Risk Factors

Natural History, Complications and Prognosis

Cardiovascular abnormalities associated with mixed connective tissue disease are rare. Presence of any of the complications listed below indicates unfavorable prognosis;

Diagnosis

Diagnostic Criteria

Symptoms

Physical examination

Gallery

Trunk
Extremities

Laboratory Findings

  • Elevated serum level of muscle enzymes (creatine kinase)
  • MCTD is characterized by anti–U1 small nuclear RNP positivity.

Imaging Findings

    • Myogenic pattern on electromyogram

Other Diagnostic Studies

    • Hypomotility or dilatation of esophagus

References

  1. Venables PJ. Mixed connective tissue disease. Lupus. 2006;15(3):132-7. PMID 1663436
  2. Jang J J, Olin J W, Fuster V. A teenager with mixed connective tissue disease presenting with an acute coronary syndrome. Vascular Medicine; 2004, Vol. 9 Issue 1, 31-34